VOYA Investment Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,587
| Closed | -$58.6K | – | 2874 |
|
|
2024
Q1 | $58.6K | Sell |
2,587
-444
| -15% | -$7.79K | ﹤0.01% | 2712 |
|
|
2023
Q4 | $39.3K | Hold |
3,031
| – | – | ﹤0.01% | 2870 |
|
|
2023
Q3 | $60.9K | Hold |
3,031
| – | – | ﹤0.01% | 2835 |
|
|
2023
Q2 | $81.4K | Buy |
3,031
+1,107
| +58% | +$47.7K | ﹤0.01% | 2839 |
|
|
2023
Q1 | $112K | Hold |
1,924
| – | – | ﹤0.01% | 2677 |
|
|
2022
Q4 | $98.1K | Sell |
1,924
-9,517
| -83% | -$660K | ﹤0.01% | 2759 |
|
|
2022
Q3 | $937K | Buy |
11,441
+9,517
| +495% | +$711K | ﹤0.01% | 1665 |
|
|
2022
Q2 | $130K | Sell |
1,924
-127
| -6% | -$11.6K | ﹤0.01% | 2551 |
|
|
2022
Q1 | $227K | Buy |
2,051
+127
| +7% | +$15.8K | ﹤0.01% | 2304 |
|
|
2021
Q4 | $186K | Sell |
1,924
-51
| -3% | -$5.08K | ﹤0.01% | 2537 |
|
|
2021
Q3 | $172K | Buy |
1,975
+12
| +0.6% | +$1.25K | ﹤0.01% | 2613 |
|
|
2021
Q2 | $304K | Sell |
1,963
-160
| -8% | -$23.2K | ﹤0.01% | 2371 |
|
|
2021
Q1 | $335K | Buy |
2,123
+85
| +4% | +$17.9K | ﹤0.01% | 2262 |
|
|
2020
Q4 | $473K | Sell |
2,038
-55
| -3% | -$12.7K | ﹤0.01% | 1957 |
|
|
2020
Q3 | $458K | Buy |
2,093
+473
| +29% | +$116K | ﹤0.01% | 1721 |
|
|
2020
Q2 | $460K | Sell |
1,620
-376
| -19% | -$111K | ﹤0.01% | 1722 |
|
|
2020
Q1 | $575K | Buy |
1,996
+45
| +2% | +$12.4K | ﹤0.01% | 1540 |
|
|
2019
Q4 | $561K | Buy |
1,951
+383
| +24% | +$83.1K | ﹤0.01% | 1828 |
|
|
2019
Q3 | $226K | Hold |
1,568
| – | – | ﹤0.01% | 2200 |
|
|
2019
Q2 | $141K | Buy |
1,568
+169
| +12% | +$13.6K | ﹤0.01% | 2384 |
|
|
2019
Q1 | $123K | Hold |
1,399
| – | – | ﹤0.01% | 2382 |
|
|
2018
Q4 | $197K | Buy |
1,399
+155
| +12% | +$26.1K | ﹤0.01% | 2226 |
|
|
2018
Q3 | $318K | Hold |
1,244
| – | – | ﹤0.01% | 2119 |
|
|
2018
Q2 | $317K | Buy |
1,244
+243
| +24% | +$60.1K | ﹤0.01% | 2114 |
|
|
2018
Q1 | $201K | Hold |
1,001
| – | – | ﹤0.01% | 2314 |
|
|
2017
Q4 | $144K | Hold |
1,001
| – | – | ﹤0.01% | 2432 |
|
|
2017
Q3 | $165K | Hold |
1,001
| – | – | ﹤0.01% | 2448 |
|
|
2017
Q2 | $136K | Buy |
1,001
+297
| +42% | +$44K | ﹤0.01% | 2508 |
|
|
2017
Q1 | $136K | Hold |
704
| – | – | ﹤0.01% | 2382 |
|
|
2016
Q4 | $99K | Hold |
704
| – | – | ﹤0.01% | 2454 |
|
|
2016
Q3 | $103 | Hold |
704
| – | – | ﹤0.01% | 2463 |
|
|
2016
Q2 | $71K | Hold |
704
| – | – | ﹤0.01% | 2524 |
|
|
2016
Q1 | $94K | Hold |
704
| – | – | ﹤0.01% | 2411 |
|
|
2015
Q4 | $140K | Hold |
704
| – | – | ﹤0.01% | 2402 |
|
|
2015
Q3 | $111K | Hold |
704
| – | – | ﹤0.01% | 2464 |
|
|
2015
Q2 | $287K | Buy |
704
+261
| +59% | +$113K | ﹤0.01% | 2296 |
|
|
2015
Q1 | $204K | Hold |
443
| – | – | ﹤0.01% | 2418 |
|
|
2014
Q4 | $249K | Hold |
443
| – | – | ﹤0.01% | 2375 |
|
|
2014
Q3 | $232K | Hold |
443
| – | – | ﹤0.01% | 2419 |
|
|
2014
Q2 | $310K | Buy |
+443
| New | +$206K | ﹤0.01% | 2329 |
|
Other funds holding KPTI
PAI
EP
VOYA Investment Management's KPTI Position: Q2 2024 in Review
VOYA Investment Management sold out of Karyopharm Therapeutics (KPTI) in Q2 2024, closing a stake of 2,587 shares — an estimated $58.6K sold.
VOYA Investment Management first reported a position in KPTI in Q2 2014 and held it in 40 quarters. The position peaked at $937K in Q3 2022. 114 funds tracked by Wall St. Rank hold KPTI as of Q2 2024.
- VOYA Investment Management reported no remaining Karyopharm Therapeutics position as of Q2 2024 after selling out during the quarter.
- VOYA Investment Management sold 2,587 Karyopharm Therapeutics shares in Q2 2024, an estimated $58.6K.
- VOYA Investment Management first reported a position in Karyopharm Therapeutics in Q2 2014 and held it in 40 quarters.
- VOYA Investment Management's Karyopharm Therapeutics position peaked at $937K in Q3 2022.
- 114 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q2 2024.
Based on VOYA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.